Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SE vs MRNA✓SelectedUSD · MRNASE vs MRNA performance historyLatest closeAs of-3.06%11/17
Stock and ETF performance explorer

SE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+473.9%
MRNA return
+840.0%
Excess return
-366.1%
Maximum drawdown
-90.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.1%-3.9%+0.9%-2.6%
7D-9.6%-17.6%+8.0%-7.6%
30D-25.9%-5.1%-20.8%-25.8%
3M-41.9%+220.8%-262.7%-54.3%
6M-21.3%+321.7%-343.0%-41.7%
YTD-45.6%+601.3%-646.8%-63.9%
1Y-52.4%+735.2%-787.6%-69.6%
3Y+84.8%+170.5%-85.7%+35.7%
5Y-77.9%-14.6%-63.3%-80.6%
All+473.9%+840.0%-366.1%+337.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling